| Institution | PI Name | Title |
|---|
| Alphavax Human Vaccines, Inc. | Smith, Jonathan F | Alphavirus Replicon Vaccines to Encephalitis Viruses |
| Auburn University at Auburn | Schneller, Stewart W | Therapeutics for Pox, Filo and Other Viral Pathogens |
| Boston Medical Center | Rice, Peter A | Immuno-Prophylaxis-Therapy & Diagnosis of Tularemia |
| Brookhaven Science Association - Brookhaven Lab | Dunn, John J | Rapid Detection and Identification of Zoonotic Pathogens |
| Burnham Institute | Strongin, Alex Y | Develop Effective Inhibitors of Anthrax Lethal Factor |
| Cangene Corporation | Stewart, Donald I.H. | Antibodies to Burkholderia type III secretion system |
| Catholic University of America | Rao, Venigalla B | A Multicomponent Anthrax Vaccine using Phage T4 Display |
| CBR Institute for Biomedical Research | Lieberman, Judy | RNA Interference as a Weapon Against Bioterrorism |
| Chemocentryx, Inc. | Howard, Maureen C | Chemokine Adjuvants for Biothreat Pathogen Vaccines |
| Chiron Corporation | Valiante, Nicholas M | Novel Adjuvants/Delivery Systems for Biodefense Vaccines |
| Chiron S.P.A. | Grandi, Guido | Novel vaccine candidates for Y. pestis from genomics |
| Colorado State University | Dow, Steven W | Antigen Presentation and Pulmonary Immunity to Plague |
| Diversa Corporation | Kimmell, Bruce E | Antibodies for BioDefense using Directed Evolution |
| Duke University | Gunn, Michael D | Novel TLR Ligand Mimetics as Adjuvants and Therapeutics |
| Dynavax Technologies Corporation | Coffman, Robert L | Immunostimulatory DNA Priming of Lung Innate Immunity |
| Dynavax Technologies Corporation | Van Nest, Gary A | Advanced anthrax vaccine made with ISS DNA formulations |
| Dynavax Technologies Corporation | Van Nest, Gary A | ISS-linked NP vaccine to control pandemic flu outbreak |
| Dynport Vaccine Company, LLC | Henderson, Ian | Fast-Track Production of a Heptavalent Botulinum Vaccine |
| Emory University | Compans, Richard W | Design and production of Virus-like Particles |
| Georgia Institute of Technology | Bunz, Uwe H.F. | Pathogen-sensing with novel poly(aryleneethynylene)s |
| Harvard University (Medical School) | Higgins, Darren E | Novel Vaccine Strategy for Listeria monocytogenes |
| Hawaii Biotech, Inc. | Weeks-Levy, Carolyn L | Preclinical Development of a Recombinant Dengue Vaccine |
| Henry M. Jackson Fdn for the Adv Mil/Med | Broder, Christopher C | Nipah virus and Hendra virus Peptide Therapeutics |
| Indiana University - Purdue University at Indianapolis | Dziarski, Roman | Antibacterial peptidoglycan recognition proteins |
| Johns Hopkins University | August, Joseph T | Dengue Epitope Vaccine,Tetravalent & MHCII-Targeted |
| Macrogenics, Inc. | Sykes, Kathryn F | Discovery of new anti-bacteremia vaccines for anthrax |
| Rockefeller University | Fischetti, Vincent A | Pathogen-specific drug targets for weaponized bacteria |
| Stanford University | Clayberger, Carol | Granulysin Derived Immunotherapeutics for Biodefense |
| Surface Logix, Inc. | Sweetnam, Paul M | Novel Antibiotics against Gram-Negative Bacteria |
| Thomas Jefferson University | Strayer, David S | Focusing Immunity vs. Botulinum Toxin with Cytokine DNA |
| Tulane University of Louisiana | Clelments, John D | Novel adjuvants for biodefense vaccines |
| University of Massachusetts Med Sch - Worcester | Lu, Shan | Multi-gene plague vaccine with expanded protection |
| University of Med/Dent NJ - Newark | Alland, David | Detection of Select Agents in Single-Well Assays |
| University of Alabama at Birmingham | Brouillette, Wayne J | A Novel Target for New Anti-Anthrax Drugs |
| University of Alabama at Birmingham | Michalek, Suzanne M | Development of a Mucosal Vaccine Against F. tularensis |
| University of California - Berkeley | Mathies, Richard A | Analyzer for 2D Multiplex Detection of Infectious Agents |
| University of California - Irvine | Felgner, Philip L | Scanning the F. tularensis Proteome for Vaccine Antigens |
| University of California - Los Angeles | Modlin, Robert L | CD1-targeted Vaccination against Tuberculosis |
| University of California - Los Angeles | Morrison, Sherie L | Immunotherapeutics to Prevent & Treat BoNT Intoxication |
| University of California - San Diego | Carson, Dennis A | Optimized Synthetic TLR Ligands for Biodefense |
| University of California - San Francisco | Marks, James D | Development of botulinum neurotoxin immunotherapy |
| University of Colorado at Boulder | Rowlen, Kathy L | Development of Diagnostic Microarray for Influenza A |
| University of Illinois at Chicago | Johnson, Michael E | Novel Therapeutics for Bacillus anthracis |
| University of Kansas - Lawrence | David, Sunil A | Gram-Negative Sepsis: Pharmacophore-Based Therapeutics |
| University of Maryland Balt Prof School | Nataro, James P | Live Vector Vaccines Against Agents of Bioterror |
| University of Michigan at Ann Arbor | Cease, Kemp B | Molecularly Targeted Vaccines for Anthrax |
| University of New Mexico - Albuquerque | Hjelle, Brian L | Cell Entry Inhibitors for Sin Nombre Virus |
| University of Pittsburgh at Pittsburgh | Falo, Louis D | Development of Immunotherapeutics for Biodefense |
| University of Texas - Austin | Iverson, Brent L | Anthrax Antidote in Animals |
| University of Texas Medical Branch - Galveston | Barrett, Alan | Antiviral Activity of Thioaptamers Against West Nile Virus |
| University of Texas SW Medical Center - Dallas | Thorpe, Philip E | Novel Anti-Viral Agents for Treating Lassa Fever |
| University of Texas SW Medical Center - Dallas | Vitetta, Ellen S | A Novel Recombinant Protein Vaccine Against Ricin Toxin |
| University of Toronto | Mogridge, Jeremy S | Development and testing of anthrax toxin inhibitors |
| University of Virginia - Charlottesville | Petri, William A | Rapid Diagnostics for Category B Enteropathogens |
| Washington University | Curtiss, Roy | Vaccines to Protect Against Bacterial Enteropathogens |